A Virginia lawyer heavily involved in Roundup litigation has been charged with attempted extortion for “threatening to inflict substantial financial and reputational harm” on an unnamed chemical company unless he received $200 million in “consulting fees,” the Justice Department says.

Legal challenges facing Bayer for health concerns allegedly caused by the use of glyphosate more than doubled in the last quarter, the company recently disclosed to investors.

A trial in St. Louis involving a plaintiff who alleges exposure to Roundup caused her non-Hodgkin lymphoma has been delayed indefinitely, leading to speculation that Bayer and plaintiffs’ lawyers need the time to work out a settlement.

With an eye on the future of agriculture and the need to address shareholders and customers expectations, Bayer confirmed an ambitious plan to address climate change and a more sustainable farming future during events in Monheim, Germany, this week.

Elanco will become the second-largest animal health company in the world following its acquisition of Bayer’s animal health business in a $7.6-billion deal announced Tuesday by both companies.

A California state court judge has significantly reduced damages awarded to a couple whose non-Hodgkin lymphoma was blamed on Roundup exposure, cutting their overall award from more than $2 billion to $86.7 million.